Research facility · founded 1892

The Wistar Institute

Philadelphia, United States · wistar.org

Manage this page

Citations, last 5 years: 13.8k
Works, last 5 years: 2 014
h-index: 580
Scientists listed: 246
Grants since 2016: 630

Grants received

2017–2022 · research · R50

Advancing Cancer Research through Comprehensive Proteomics and Metabolomics Analyses

Hsin-Yao Tang · The Wistar Institute · funded by National Institutes of Health

$188.5k

2017–2022 · research · R01

Targeting TERT in Melanoma

Jessie Villanueva · The Wistar Institute · funded by National Institutes of Health

$49k

2017–2027 · research · R50

Advancing Cancer Research through Comprehensive Proteomics and Metabolomics Analyses

Hsin-Yao Tang · The Wistar Institute · funded by National Institutes of Health

$237.1k

2017–2024 · research · R35

Tumor Plasticity

Dario C Altieri · The Wistar Institute · funded by National Institutes of Health

$1.1M

2017–2022 · cooperative agreement · U54

Rational approaches to melanoma therapy

Michael Davies · The Wistar Institute · funded by National Institutes of Health

$120k

2017–2023 · cooperative agreement · U54

Rational approaches to melanoma therapy (PDXNet Administrative Supplement to R01CA241148)

Michael Davies · The Wistar Institute · funded by National Institutes of Health

$120k

2017–2022 · research · R01

Multivalent DNA vaccine-mediated protection against Tuberculosis

David B. Weiner · The Wistar Institute · funded by National Institutes of Health

$405.6kTuberculosis Research and Epidemiology

2017–2022 · research · R01

Negative regulation of myeloid-derived suppressive cells in cancer

Serge Y Fuchs · The Wistar Institute · funded by National Institutes of Health

$79.2kImmune cells in cancer

2017–2019 · cooperative agreement · U54

Rational approaches to melanoma therapy

Michael Davies · The Wistar Institute · funded by National Institutes of Health

$2.9M

2017–2018 · contract · N01

CLINICAL DEVELOPMENT OF TWO REPLICATION-DEFECTIVE CHIMPANZEE ADENOVIRUS (ADC) VECTORS, TERMED ADC6 AND ADC7

Hildegund Ertl · The Wistar Institute · funded by National Institutes of Health

$153.4k

2017–2023 · cooperative agreement · U54

Rational approaches to melanoma therapy (PDXNet Administrative Supplement to R01CA121118)

Michael Davies · The Wistar Institute · funded by National Institutes of Health

$120k

2017–2028 · cooperative agreement · U54

Rational Approaches to Melanoma Therapy

Michael Davies · The Wistar Institute · funded by National Institutes of Health

$1.2M

2017–2022 · research · R01

Effect of the aged microenvironment on tumor dormancy

Ashani T Weeraratna · The Wistar Institute · funded by National Institutes of Health

$434.6kCancer Cells and Metastasis

2017–2020 · research · R21

Exploring Cell-free Glycomic Interactions in HIV-associated Neurological Disorders

Mohamed Abdel Mohsen · The Wistar Institute · funded by National Institutes of Health

$211.4kHIV Research and Treatment

2017–2024 · research · R35

Tumor Plasticity

Dario C Altieri · The Wistar Institute · funded by National Institutes of Health

$1.1M

2017–2022 · research · R01

Targeting TERT in Melanoma

Jessie Villanueva · The Wistar Institute · funded by National Institutes of Health

$92.6k

2017–2022 · research · R50

Advancing Cancer Research through Comprehensive Proteomics and Metabolomics Analyses

Hsin-Yao Tang · The Wistar Institute · funded by National Institutes of Health

$188.5k

2017–2022 · cooperative agreement · U54

Rational approaches to melanoma therapy

Michael Davies · The Wistar Institute · funded by National Institutes of Health

$1.4M

2017–2021 · research · R01

Condensin connects 3D genome organization, chromosomal segregation, and gene regulation via its interactions with transcription-related factors

Kenichi Noma · The Wistar Institute · funded by National Institutes of Health

$413.7kGenomics and Chromatin Dynamics

2017–2023 · cooperative agreement · U54

Rational approaches to melanoma therapy

Michael Davies · The Wistar Institute · funded by National Institutes of Health

$1.4M

2017–2018 · grant · S10

Purchase of a Q Exactive HF mass spectrometer system for metabolomics

David W. Speicher · The Wistar Institute · funded by National Institutes of Health

$600kMetabolomics and Mass Spectrometry Studies

2017–2019 · research · R21

Exploring Cell-free Glycomic Interactions in HIV-associated Neurological Disorders

Mohamed Abdel Mohsen · The Wistar Institute · funded by National Institutes of Health

$295.9kHIV Research and Treatment

2017–2028 · cooperative agreement · U54

Rational Approaches to Melanoma Therapy

Michael Davies · The Wistar Institute · funded by National Institutes of Health

$635.5k

2017–2022 · research · R01

Targeting TERT in Melanoma

Jessie Villanueva · The Wistar Institute · funded by National Institutes of Health

$426.3k

2017–2027 · research · R50

Advancing Cancer Research through Comprehensive Proteomics and Metabolomics Analyses

Hsin-Yao Tang · The Wistar Institute · funded by National Institutes of Health

$237.1k

2017–2021 · research · R01

Condensin connects 3D genome organization, chromosomal segregation, and gene regulation via its interactions with transcription-related factors

Kenichi Noma · The Wistar Institute · funded by National Institutes of Health

$413.7kGenomics and Chromatin Dynamics

2017–2024 · research · R01

Targeting TERT in Melanoma

Jessie Villanueva · The Wistar Institute · funded by National Institutes of Health

$464.6k

2017–2024 · research · R35

Tumor Plasticity

Dario C Altieri · The Wistar Institute · funded by National Institutes of Health

$1.1M

2017–2024 · research · R35

Tumor Plasticity

Dario C Altieri · The Wistar Institute · funded by National Institutes of Health

$1.1M

2017–2022 · cooperative agreement · U54

Rational approaches to melanoma therapy

Michael Davies · The Wistar Institute · funded by National Institutes of Health

$120k

2017–2022 · research · R01

Multivalent DNA vaccine-mediated protection against Tuberculosis

David B. Weiner · The Wistar Institute · funded by National Institutes of Health

$908.4kTuberculosis Research and Epidemiology

2017–2024 · research · R35

Tumor Plasticity

Dario C Altieri · The Wistar Institute · funded by National Institutes of Health

$1.1M

2017–2022 · research · R01

Targeting TERT in Melanoma

Jessie Villanueva · The Wistar Institute · funded by National Institutes of Health

$439.3k

2017–2019 · research · R01

Condensin connects 3D genome organization, chromosomal segregation, and gene regulation via its interactions with transcription-related factors

Kenichi Noma · The Wistar Institute · funded by National Institutes of Health

$413.7kGenomics and Chromatin Dynamics

2017–2023 · research · R01

Negative regulation of myeloid-derived suppressive cells in cancer

Serge Y Fuchs · The Wistar Institute · funded by National Institutes of Health

$461.8kImmune cells in cancer

2017–2022 · grant · DP2

Epigenetic regulation through the formation and resolution of R loops

Kavitha Sarma · The Wistar Institute · funded by National Institutes of Health

$2.9M

2017–2018 · grant · S10

Purchase of a Seahorse Bioscience XF Analyzer

Maureen E. Murphy · The Wistar Institute · funded by National Institutes of Health

$188.3k

2017–2022 · research · R01

Targeting TERT in Melanoma

Jessie Villanueva · The Wistar Institute · funded by National Institutes of Health

$470.2k

2017–2023 · research · R01

Regulation of PRC2 functions by PARP1

Italo Tempera · The Wistar Institute · funded by National Institutes of Health

$383.3kPARP inhibition in cancer therapy

2017–2020 · research · R01

Effect of the aged microenvironment on tumor dormancy

Ashani T Weeraratna · The Wistar Institute · funded by National Institutes of Health

$421.6kCancer Cells and Metastasis